Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection
1 other identifier
interventional
101
1 country
1
Brief Summary
The aim of this study is to evaluate the usefulness of pCLE (probe-based confocal laser endomicroscopy) compared with conventional chromoendoscopy (CE) for delineating the margin of early gastric cancer (EGC) with endoscopic submucosal dissection (ESD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 10, 2014
CompletedFirst Posted
Study publicly available on registry
July 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2015
CompletedApril 1, 2019
December 1, 2015
1.2 years
July 10, 2014
March 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complete resection rate
Complete resection is defined as en bloc resection with negative horizontal, vertical margin and distance from marking dot to histologic margin will be measured.
One week after ESD
Secondary Outcomes (4)
Horizontal cut end-positive
Within the first 30 days after ESD
vertical cut end-positive
Within the first 30 days after ESD
procedure time
1 day
adverse event
Within the first 30 days after ESD
Study Arms (2)
probe-based confocal laser endomicroscopy (pCLE) group
EXPERIMENTALchromoendoscopy (CE) group
ACTIVE COMPARATORInterventions
Before ESD, the lesion will be observed either by pCLE or by CE to determine proximal and distal margin of the lesion. In the pCLE group, after injection of intravenous fluorescein, the lesion will be observed using a flexible confocal miniprobe. In the CE group, the lesion will be observed conventionally under white light after spraying indigocarmine directly via the forceps channel. Marking dots will be placed on both margins using needle knife. Then several dots will be marked on the surrounding normal mucosa 5 mm from the tumor with Argon plasma coagulation. After injection of saline solution with epinephrine into the submucosa, an initial cut will be made with needle knife outside the line of surrounding marks. An insulation-tipped (IT) knife will be inserted into initial cut, and electrosurgical current will be applied to complete the incision around the tumor. After the circumferential cut, the submucosa will be dissected with the IT knife.
Eligibility Criteria
You may qualify if:
- Consecutive patients diagnosed as EGC and treated by ESD with following criteria:1) Differentiated mucosal cancer without ulcer 2) Differentiated mucosal cancer with ulcer, ≤ 3 cm 3) Differentiated minute (\<500 μm) submucosal invasive cancer, ≤ 3 cm 4) Undifferentiated mucosal cancer without ulcer, ≤ 2 cm
- Consecutive patients diagnosed as low- and high-grade dysplasia with suspicion of EGC and treated by ESD
You may not qualify if:
- Coagulopathy : International normalized ratio \[INR\] \> 1.5 or platelet count \<50,000 cell/cubic millimeter)
- Impaired renal function : Cr \> 1.2 mg/dL
- Pregnancy or breast-feeding
- Age \< 20 years
- Allergy to fluorescein dye
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance Hospital
Seoul, 120-752, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2014
First Posted
July 14, 2014
Study Start
November 1, 2013
Primary Completion
January 20, 2015
Study Completion
January 20, 2015
Last Updated
April 1, 2019
Record last verified: 2015-12